Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Meridith E. Erwin

Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.

scientific article

Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods

scientific article published in April 2000

Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines

scientific article published on 01 February 1999

Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United States ⬇️

scientific article published on 01 March 1998

Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates ⬇️

scientific article published on September 1, 1992

Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group

scientific article

Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.

scientific article

Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis ⬇️

scientific article published on 01 February 1995

Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems

scientific article

Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates ⬇️

scientific article published on 01 September 1991

Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group

scientific article

Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative ba ⬇️

scientific article published on 01 October 1991

Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species

scientific article published on August 1, 1992

Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella ⬇️

scientific article published on November 1, 1991

Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis group

scientific article published on 01 September 1990

Avoparcin, a glycopeptide used in animal foods: Antimicrobial spectrum and potency tested against human isolates from the United States ⬇️

scientific article published on December 1, 1997

Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae ⬇️

scientific article published on May 1, 1995

CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum ⬇️

scientific article (publication date: February 1992)

Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines

scientific article

Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae

scientific article published on 01 September 1992

Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals

scientific article

Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae

scientific article published on September 1993

Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates

scientific article published on June 1999

Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group

scientific article published in June 1999

Critical appraisal of E test for the detection of fluoroquinolone resistance

scientific article published on 01 July 1996

Determination of MIC quality control ranges for ABT-733, a novel ketolide antimicrobial agent. Quality Control Study Group

scientific article published on June 2000

Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines ⬇️

scientific article published on September 1, 1991

Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group

scientific article published on 01 July 2000

Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone

scientific article published on 01 November 1999

Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin ⬇️

scientific article published on March 1, 1992

Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin ⬇️

scientific article published on December 1, 1991

E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates

scientific article published on December 1993

Emergence of cefepime-resistance in Klebsiella oxytoca clinical isolate due to alteration in the outer membrane permeability

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

scientific article published on February 1995

Emerging multiply resistant enterococci among clinical isolates. II. Validation of the etest to recognize glycopeptide-resistant strains

scientific article published in February 1995

Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates

scientific article

Evaluation of antimicrobial sensitivity of 87 clinical isolates of vancomycin-resistant enterococci

scientific article

Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areas

scientific article published on 01 August 2000

Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis

scientific article published on 01 December 1994

Evaluation of the Etest for determinations of antimicrobial spectrum and potency against anaerobes associated with bacterial vaginosis and peritonitis

scientific article published in June 1995

False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae

scientific article

False resistance to metronidazole by E-test among anaerobic bacteria investigations of contributing test conditions and medium quality

scientific article published on 01 February 1996

Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group

scientific article

Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin

scientific article published on November 1, 1992

In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

scientific article

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin

scientific article

In vitro activity of CP-74667 compared with four other fluoroquinolones

scientific article published on 01 August 1992

In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds

scientific article

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones

scientific article published on April 1, 1992

In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester

scientific article published in November 1991

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers

scientific article published in August 1993

In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination against Legionella species

scientific article published on 01 November 1990

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

scientific article

In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones

scientific article

In vitro antimicrobial activity of RU-59863, A C-7 catechol substituted cephalosporin ⬇️

scientific article published on 01 June 1997

In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds

scientific article

In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) application

scientific article

In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates

scientific article published on July 1991

In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin ⬇️

scientific article published on May 1, 1991

In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin ⬇️

scientific article published on January 1, 1992

In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry ⬇️

scientific article published on 01 September 1998

In-vitro activity of FK-037, a new parenteral cephalosporin

scientific article published on 01 January 1994

In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates

scientific article published on 01 December 1993

Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose

scientific article published on April 1996

Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials

scientific article published in October 1993

Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.

scientific article published on October 1993

Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan

scientific article published on February 1991

Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium ⬇️

scientific article published on February 1, 1992

Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-μg disks ⬇️

scientific article published on May 1, 1992

Interpretive criteria for DU-6859a disk diffusion tests using 5-micrograms disks

scientific article published on 01 February 1994

Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae

scientific article published on 01 October 1993

Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates

scientific article published on April 1992

Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium ⬇️

scientific article published on May 1, 1992

MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin ⬇️

scientific article published on May 1, 1992

MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin ⬇️

scientific article published on January 1, 1992

Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Con

scientific article

Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1.

scientific article published on June 1995

Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group

scientific article published on 01 February 1998

Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria

scientific article published on 01 March 1993

New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria

scientific article published on 01 January 1992

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy ⬇️

scientific article published on October 1, 1997

Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group

scientific article published in July 1992

Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin

scientific article published in May 1992

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group

scientific article

Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246.

scientific article published in March 1991

Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Cli

scientific article published on 01 February 1996

Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.

scientific article

Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres.

scientific article

Roxithromycin in-vitro susceptibility testing of Haemophilus influenzae by NCCLS methods. National Committee for Clinical Laboratory Standards

scientific article published on 01 October 1993

Studies to establish quality control ranges for SB-265805 (LB2030) when using National Committee for Laboratory Standards antimicrobial susceptibility test methods. Quality Control Study Group

scientific article published on January 1999

Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis

scientific article published on March 1996

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program

scientific article

Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolates

scientific article published on 01 February 2001

Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group

scientific article published in October 1994

Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards

scientific article

Paulina is supported by:

About Paulina

Help